2005Journal of Zhengzhou UniversityRequires access

Expression of TGF-β_1 in human breast cancer

Yuping Wang

Open publisher page 0 citations

Abstract

Aim: To study the relationship between the expression of TGF-β_1 in breast cancer and different clinialpathological stages. Methods: Immunohistochemical streptavidin/peroxidase technique was used to detect the expression of TGF-β_1 in 12 cases of breast cancer in situ,50 cases of invasive cancer,and 15 cases of normal breast tissue.Among 62 cases of breast cancer,17 cases were at 0 ~Ⅰ stage,and 45 case were at Ⅱ~Ⅲ stage according to TNM staging.Results: The expression of TGF-β_1 had significant difference between the normal breast tissue group and the breast cancer group( P=0.041),between the 0 ~Ⅰstage and Ⅱ~Ⅲstage in the breast cancer(P=0.026),and between the group with axillary lymph node metastasis and that without (P=0.018).But there was no significant difference between different histological grades(P=0.538). Conclusion: TGF-β_1 may be useful to estimate the clinical pathological stage and the focus of micrometastasis in breast cancer.

About this research paper

What this paper is about

Aim: To study the relationship between the expression of TGF-β_1 in breast cancer and different clinialpathological stages. Methods: Immunohistochemical streptavidin/peroxidase technique was used to detect the expression of TGF-β_1 in 12 cases of breast cancer in situ,50 cases of invasive cancer,and 15 cases of normal breast tissue.Among 62 cases of breast cancer,17 cases were at 0 ~Ⅰ stage,and 45 case were at Ⅱ~Ⅲ stage according to TNM staging.Results: The expression of TGF-β_1 had significant difference between the normal breast tissue group and the breast cancer group( P=0.041),between the 0 ~Ⅰstage and Ⅱ~Ⅲstage in the breast cancer(P=0.026),and between the group with axillary lymph node metastasis and that without (P=0.018).But there was no significant difference between different histological grades(P=0.538). Conclusion: TGF-β_1 may be useful to estimate the clinical pathological stage and the focus of micrometastasis in breast cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aim: To study the relationship between the expression of TGF-β_1 in breast cancer and different clinialpathological stages. Methods: Immunohistochemical streptavidin/peroxidase technique was used to detect the expression of TGF-β_1 in 12 cases of breast cancer in situ,50 cases of invasive cancer,and 15 cases of normal breast tissue.Among 62 cases of breast cancer,17 cases were at 0 ~Ⅰ stage,and 45 case were at Ⅱ~Ⅲ stage according to TNM staging.Results: The expression of TGF-β_1 had significant difference between the normal breast tissue group and the breast cancer group( P=0.041),between the 0 ~Ⅰstage and Ⅱ~Ⅲstage in the breast cancer(P=0.026),and between the group with axillary lymph node metastasis and that without (P=0.018).But there was no significant difference between different histological grades(P=0.538). Conclusion: TGF-β_1 may be useful to estimate the clinical pathological stage and the focus of micrometastasis in breast cancer.

Key concepts: Breast cancer, Medicine, Stage (stratigraphy), Micrometastasis, Immunohistochemistry, Pathological, Oncology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of TGF-β_1 in human breast cancer — Research Paper | ScholarLens